ARTICLE | Company News
Organon and Sanofi-Synthelabo pentasaccharide deal
September 5, 2000 7:00 AM UTC
The companies will market and develop synthetic antithrombotic pentasaccharide worldwide. In the U.S., Canada and Mexico the companies will form a joint marketing venture. Elsewhere, except Japan, San...